Search

Evaluative skill, the ability to accurately assess ideas in terms of originality or creativity, is a critical component of creativity. It involves discarding bad ideas and discerning ideas that are worthwhile to pursue. In light of the growing research on the association between individuals' evaluative skill and divergent thinking (DT), a research synthesis is needed to clarify discrepant results. Therefore, we examined the relationship between DT and evaluative skill with a three‐level meta‐analytic approach. Based on 96 effect sizes in 20 studies with a total sample of 3,019 participants, results indicated that DT was positively associated with evaluative skill, r =.13 (95% CI [.07,.20], p <.001). Follow‐up moderator analyses revealed that the type of DT tests, the source of ideas, and the type of evaluation tasks were significant moderators. Compared with Instances, Line Meanings, and Consequences, the relationship was (a) weaker when the Uses task was used as the DT test, (b) stronger when the evaluation task was based on Uses, and (c) stronger when people rated their own ideas than when they rated others. The findings implied that DT and evaluative skill are conceptually distinct but interrelated and suggested ways to enhance evaluative skill. [ABSTRACT FROM AUTHOR]

Upper GI–tracheobronchial fistula is a morbid condition with high mortality. It is a challenge for endoscopists because currently available treatments have severe limitations. In this study we assessed the efficacy and safety of an occluder we invented for endoscopic closure of refractory upper GI–tracheobronchial fistulas. This was a prospective, single-arm, single-center trial conducted between September 2020 and March 2022. All patients undergoing occluder placement were eligible to enroll. The primary endpoints were clinical success rate (CSR) and complete closure rate (CCR) at 3 months and safety. Secondary efficacy endpoints were technical success rates, CSRs and CCRs at 1 and 6 months, near-complete closure rates, change from baseline in body mass index (BMI), and health-related quality of life (HRQoL) at 1, 3, and 6 months. Twenty-eight patients (mean age, 63.2 years; 23 men) were enrolled. Eighteen through-the-scope occluders (TTSOs) and 10 through-the-overtube occluders (TTOOs) were implanted, with a technical success rate of 100%. The mean procedure time for the TTSO and TTOO groups were 28.0 ± 8.0 minutes and 31.8 ± 7.7 minutes, respectively. The CSRs at 1, 3, and 6 months were 92.9%, 96.4%, and 92.0% and the CCRs were 60.7%, 60.7%, and 60.0%, respectively. The mean BMI at 3 and 6 months and HRQoL at 1, 3, and 6 months were significantly increased compared with baseline (P <.05). Two completely occluded fistulas had 1-sided or complete healing by coverage of granulation tissue and re-epithelialized mucosa at a follow-up of 6 and 12 months. All 14 adverse events were either mild and transient or easily corrected. Our clinical outcomes suggest that this novel GI occluder is a safe and effective salvage option for patients with refractory upper GI–tracheobronchial fistulas. (Clinical trial registration number: ChiCTR2000038566.) [ABSTRACT FROM AUTHOR]